Views | |
---|---|
Tisagenlecleucel (chimeric antigen receptor T-cells targeting CD19) for patients with relapsed/refractory B-cell acute lymphoblastic leukemia: asystematic review and cost-utility analysis from a Spanish perspective | 237 |
June 2023 | July 2023 | August 2023 | September 2023 | October 2023 | November 2023 | December 2023 | |
---|---|---|---|---|---|---|---|
Tisagenlecleucel (chimeric antigen receptor T-cells targeting CD19) for patients with relapsed/refractory B-cell acute lymphoblastic leukemia: asystematic review and cost-utility analysis from a Spanish perspective | 3 | 3 | 2 | 2 | 0 | 4 | 3 |
Views | |
---|---|
Delgado_Tisagenlecleucel_MUESIOL.pdf | 93 |
Views | |
---|---|
United States | 86 |
Spain | 50 |
Germany | 20 |
France | 6 |
Brazil | 5 |
Saudi Arabia | 5 |
United Kingdom | 4 |
Sweden | 4 |
Austria | 3 |
Colombia | 3 |
Views | |
---|---|
San Ramon | 25 |
Barcelona | 17 |
Madrid | 13 |
Redwood City | 12 |
Hamburg | 7 |
Fremont | 6 |
Piracicaba | 4 |
Blue Bell | 3 |
Bogotá | 3 |
Granada | 3 |